FSD Pharma Inc. submitted a Form 6-K to the SEC reporting that the filing is for the month of April 2024, signed by CFO Nathan Coyle on April 17, 2024. No significant events or quantitative data were mentioned in this filing.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.